Factorial Funds is a Menlo Park-based venture capital firm founded in 2021 that specializes in early-stage and growth equity investments within the technology sector. The firm is “purpose-built for the AI era,” focusing on transformative technologies across the artificial intelligence (AI) value chain, robotics, cloud infrastructure, and scalable software solutions. They made an early investment in actAVA because of our reputation and AI-first architecture from the outset.
SemperVirens connects portfolio companies with a network of over 1,500 HR leaders and Fortune 500 executives to accelerate go-to-market strategies. They choose to invest in actAVA because they understand our healthcare AI orchestration platform that accelerates the creation, training, and deployment of compliant, enterprise grade AI solutions. There is a need for our tools across their portfolio companies and their LPs.
Ikigai Venture Partners backs premier healthcare technology and tech-enabled services firms across Seed, Series A, and Series B rounds, primarily investing in high-potential companies from their earlier healthcare funds. They chose to invest in actAVA because it aligns with their mission to scale transformative healthcare technologies, and they actively support actAVA’s revenue growth, organizational scaling, and operational efficiency.
Don't give your agentic future away to a single model provider. Don't mistake consumer tools in the business for real, safe Enterprise Agentic Tools. Enable your citizen developers to create and manage the AI Agents they need to run their part of your business. actAVA is the AI factory for healthcare.
Connect with us today to discover how actAVA KORA, CHRYSO, and our team of experts can supercharge your pathway to workforce transformation through agentic AI.